Real-time enrollment status for this rsv infection clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:22 AM UTC
| NCT Number | NCT05655182 |
| Recruiting Status | Recruiting |
| Condition | RSV infection |
| Phase | PHASE1 |
| Target Enrollment | 137 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Blue Lake Biotechnology Inc. |
| Last Updated on CT.gov | June 3, 2026 (Jun 3, 2026) |
As of July 18, 2026: Clinical trial NCT05655182 is currently recruiting participants. This phase1 study for rsv infection is actively seeking new participants at 15 locations across the United States. The study is sponsored by Blue Lake Biotechnology Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05655182 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05655182 was last updated Jun 3, 2026 (June 3, 2026). HelloStudys verifies this status automatically.